Keystone Heart

Keystone Heart aspires to be the world leader in embolic cerebral protection for cardiovascular procedures. To develop and manufacture cerebral protection devices, focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, AF ablation and other structural heart procedures. Cerebral function is the essence of quality of life. Preserving brain reserve throughout medical procedures is a key component to procedural success and patient care.

Henry Hauser

Vice President, Clinical Operations

1 past transactions

510 Kardiac Devices

Acquisition in 2020
510 Kardiac Devices provides novel cardiovascular devices intended to assist in cardiovascular surgical procedures. Their intuitive platform provides physicians with an increased level of device control, functionality, and visibility. These features will make transseptal punctures more effective and efficient to perform and minimize costly complications. 510 Kardiac Devices is headquartered in Mableton, Georgia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.